{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:16:17Z","timestamp":1791065777452,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jtct.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:25:19Z","timestamp":1626344719000},"page":"938.e1-938.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients"],"prefix":"10.1016","volume":"27","author":[{"given":"Haris","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukaib","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet","family":"Dadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monzr M.","family":"Al Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.07.008_bib0001","unstructured":"Johns Hopkins University & Medicine Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available at: https:\/\/coronavirus.jhu.edu\/map.html. Accessed July 27, 2021."},{"key":"10.1016\/j.jtct.2021.07.008_bib0002","unstructured":"Centers for Disease Control and Prevention. COVID-19: your health. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/index.html. Accessed July 27, 2021."},{"issue":"27","key":"10.1016\/j.jtct.2021.07.008_bib0003","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.008_bib0004","unstructured":"US Food & Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020 Announcement. Available at: https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/vaccines-and-related-biological-products-advisory-committee-december-10-2020-meeting-announcement#event-materials. Accessed July 27, 2021."},{"issue":"11","key":"10.1016\/j.jtct.2021.07.008_bib0005","first-page":"10","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"384","author":"Skowronski","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtct.2021.07.008_bib0006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.008_bib0007","unstructured":"US Food & Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting December 17, 2020 Announcement. Available at: https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/vaccines-and-related-biological-products-advisory-committee-december-17-2020-meeting-announcement#event-materials. Accessed July 27, 2021."},{"key":"10.1016\/j.jtct.2021.07.008_bib0008","unstructured":"Baum SG. Allergic reactions to the Pfizer-BioNTech and Moderna COVID-19 vaccines: early reports. Available at: https:\/\/www.jwatch.org\/na53087\/2021\/01\/28\/allergic-reactions-pfizer-biontech-and-moderna-covid-19. Accessed July 27, 2021."},{"issue":"3","key":"10.1016\/j.jtct.2021.07.008_bib0009","doi-asserted-by":"crossref","first-page":"519","DOI":"10.20892\/j.issn.2095-3941.2020.0289","article-title":"COVID-19 in cancer patients: risk, clinical features, and management","volume":"17","author":"Liu","year":"2021","journal-title":"Cancer Biol Med"},{"issue":"23","key":"10.1016\/j.jtct.2021.07.008_bib0010","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1182\/bloodadvances.2020003170","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a report from ASH Research Collaborative Data Hub","volume":"4","author":"Wood","year":"2020","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jtct.2021.07.008_bib0011","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41409-020-0931-4","article-title":"COVID-19 outcomes in patients with hematologic disease","volume":"55","author":"Malard","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2021.07.008_bib0012","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jtct.2021.07.008_bib0013","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2021.07.008_bib0014","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2021.07.008_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.idc.2019.02.007","article-title":"Vaccination of the Stem cell transplant recipient and the hematologic malignancy patient","volume":"33","author":"Kamboj","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"21","key":"10.1016\/j.jtct.2021.07.008_bib0016","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jtct.2021.07.008_bib0017","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2213-2600(20)30247-2","article-title":"Testing for COVID-19","volume":"8","author":"Burki","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtct.2021.07.008_bib0018","unstructured":"Centers for Disease Control and Prevention. COVID-19 testing overview. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/testing.html. Accessed July 27, 2021."},{"issue":"2","key":"10.1016\/j.jtct.2021.07.008_bib0019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.beha.2006.09.009","article-title":"Immune reconstitution following hematopoietic stem-cell transplantation","volume":"20","author":"Geddes","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.jtct.2021.07.008_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccine: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2021.07.008_bib0021","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/bmt.2017.24","article-title":"A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients","volume":"52","author":"Natori","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2021.07.008_bib0022","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/bloodadvances.2020003749","article-title":"Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation","volume":"5","author":"Baumrin","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.07.008_bib0023","unstructured":"National Comprehensive Cancer Network. Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. Available at: https:\/\/www.nccn.org\/docs\/default-source\/covid-19\/2021_covid-19_vaccination_guidance_v2-0.pdf. Accessed July 27, 2021."},{"key":"10.1016\/j.jtct.2021.07.008_bib0024","unstructured":"American Society of Hematology. ASH-ASTCT COVID-19 vaccination for HCT and CAR T cell recipients: frequently asked questions. Available at: https:\/\/www.hematology.org\/covid-19\/ash-astct-covid-19-vaccination-for-hct-and-car-t-cell-recipients. Accessed July 27, 2021."},{"issue":"8","key":"10.1016\/j.jtct.2021.07.008_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic stem cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721010733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721010733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:06:47Z","timestamp":1763003207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721010733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2666636721010733"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.008","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}